Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNexus Gene Lab (BGLC) Total Current Liabilities (2018 - 2025)

Historic Total Current Liabilities for BioNexus Gene Lab (BGLC) over the last 8 years, with Q3 2025 value amounting to $678023.0.

  • BioNexus Gene Lab's Total Current Liabilities fell 5207.87% to $678023.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $678023.0, marking a year-over-year decrease of 5207.87%. This contributed to the annual value of $2.0 million for FY2024, which is 1964.41% up from last year.
  • According to the latest figures from Q3 2025, BioNexus Gene Lab's Total Current Liabilities is $678023.0, which was down 5207.87% from $1.8 million recorded in Q2 2025.
  • Over the past 5 years, BioNexus Gene Lab's Total Current Liabilities peaked at $3.0 million during Q1 2021, and registered a low of $678023.0 during Q3 2025.
  • In the last 5 years, BioNexus Gene Lab's Total Current Liabilities had a median value of $1.7 million in 2024 and averaged $1.8 million.
  • In the last 5 years, BioNexus Gene Lab's Total Current Liabilities skyrocketed by 688273.98% in 2021 and then tumbled by 5207.87% in 2025.
  • BioNexus Gene Lab's Total Current Liabilities (Quarter) stood at $2.3 million in 2021, then fell by 13.94% to $2.0 million in 2022, then decreased by 18.62% to $1.6 million in 2023, then grew by 19.64% to $2.0 million in 2024, then crashed by 65.25% to $678023.0 in 2025.
  • Its Total Current Liabilities was $678023.0 in Q3 2025, compared to $1.8 million in Q2 2025 and $1.6 million in Q1 2025.